DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS)

by Brocato, Rebecca, Josleyn, Matthew, Ballantyne, John, Vial, Pablo, Hooper, Jay W.
Published 2012

A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody
Response in Rabbits and Nonhuman Primates

by Kwilas, Steve, Kishimori, Jennifer M., Josleyn, Matthew, Jerke, Kurt, Ballantyne, John, Royals, Michael, Hooper, Jay W.
Published 2014

Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease

by Golden, Joseph W, Zaitseva, Marina, Kapnick, Senta, Fisher, Robert W, Mikolajczyk, Malgorzata G, Ballantyne, John, Golding, Hana, Hooper, Jay W
Published 2011

Making vaccines “on demand”: A potential solution for emerging pathogens and biodefense?

by De Groot, Anne S, Einck, Leo, Moise, Leonard, Chambers, Michael, Ballantyne, John, Malone, Robert W, Ardito, Matthew, Martin, William
Published 2013

Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure

by Haese, Nicole, Brocato, Rebecca L., Henderson, Thomas, Nilles, Matthew L., Kwilas, Steve A., Josleyn, Matthew D., Hammerbeck, Christopher D., Schiltz, James, Royals, Michael, Ballantyne, John, Hooper, Jay W., Bradley, David S.
Published 2015

A Directed Molecular Evolution Approach to Improved Immunogenicity of the HIV-1 Envelope Glycoprotein

by Du, Sean X., Xu, Li, Zhang, Wenge, Tang, Susan, Boenig, Rebecca I., Chen, Helen, Mariano, Ellaine B., Zwick, Michael B., Parren, Paul W. H. I., Burton, Dennis R., Wrin, Terri, Petropoulos, Christos J., Ballantyne, John A., Chambers, Michael, Whalen, Robert G.
Published 2011